Eleven Biotherapeutics
Eleven Biotherapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative protein-based therapeutics to address serious diseases. Leveraging proprietary protein engineering platforms, Eleven Biotherapeutics advances novel biologic drug candidates targeting unmet medical needs in ophthalmology and oncology. The company’s pipeline includes differentiated therapies designed to improve patient outcomes through targeted mechanisms of action. With a commitment to scientific excellence and strategic partnerships, Eleven Biotherapeutics aims to deliver transformative treatments that enhance quality of life for patients worldwide. The company’s research and development efforts are driven by a dedication to advancing next-generation biologics and expanding therapeutic options in areas of high clinical demand.
